UroGen Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | SellUS$168,600 | Mark Schoenberg | Individual | 12,000 | US$14.05 | |
01 Feb 24 | SellUS$78,790 | Jason Smith | Individual | 4,993 | US$15.78 | |
01 Feb 24 | SellUS$59,790 | Mark Schoenberg | Individual | 3,789 | US$15.78 | |
28 Jul 23 | BuyUS$15,000,000 | Monograph Capital Partners | Company | 1,572,327 | US$9.54 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,318,053 | 5.63% |
VC/PE Firms | 5,703,975 | 13.9% |
Hedge Funds | 5,827,173 | 14.2% |
General Public | 6,384,927 | 15.5% |
Institutions | 20,935,826 | 50.9% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,257,347 | US$55.1m | 88.6% | 0.87% | |||
3,083,430 | US$52.2m | 0% | 0.63% | |||
2,620,545 | US$44.4m | 0% | 7.64% | |||
2,569,826 | US$43.5m | 130% | 0.09% | |||
2,303,031 | US$39.0m | 0% | 0.23% | |||
1,796,589 | US$30.4m | 10.5% | 0.95% | |||
1,669,543 | US$28.3m | -2.75% | no data | |||
1,572,327 | US$26.6m | 0% | no data | |||
1,487,669 | US$25.2m | 0% | 9.74% | |||
1,369,315 | US$23.2m | 0% | no data | |||
1,300,000 | US$22.0m | 0% | 0.04% | |||
1,200,000 | US$20.3m | 0% | 0.02% | |||
840,000 | US$14.2m | 0% | 0.34% | |||
686,472 | US$11.6m | 5.89% | 0.09% | |||
673,487 | US$11.4m | -22.6% | 0.13% | |||
536,994 | US$9.1m | 9.41% | no data | |||
508,587 | US$8.6m | -3.2% | 2.5% | |||
495,606 | US$8.4m | 0% | 1.93% | |||
409,713 | US$6.9m | -3.81% | 0.38% | |||
408,693 | US$6.9m | 0% | no data | |||
380,342 | US$6.4m | -14.5% | no data | |||
326,941 | US$5.5m | 0% | no data | |||
323,952 | US$5.5m | 3.66% | no data | |||
288,267 | US$4.9m | 12.9% | 4.01% | |||
270,000 | US$4.6m | -15.6% | 0.98% |